Welcome to Thrombosis and Haemostasis

(1) Research Center On Thromboembolic Disorders and Antithrombotic Therapies, Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy

(1) Karolinska Institute, Department of Medicine-Solna, Clinical Pharmacology Unit, Karolinska University Hospital-Solna, Stockholm, Sweden

(1) Centre for Cardiovascular Sciences, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

(1) University of Padua Medical School, Department of Cardiologic, Thoracic and Vascular Sciences, Second Chair of Internal Medicine, Padua, Italy; (2) Department of Laboratory Diagnostics and Cellular Therapy, IRCCS, C.R.O., Aviano, Pordenone, Italy; (3) Pharmaceutical Chemistry and Pharmacology Department, University of Padua, Italy

(1) Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan; (2) Department of Biochemistry and Biophysics, University of Rochester School, Rochester, New York, USA

(1) Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, Ontario, Canada; (2) Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada; (3) Department of Medicine, McMaster University, Hamilton, Ontario, Canada

(1) Heilongjiang Key Laboratory of Blood and Hematopoietic System Diseases, Heilongjiang Institute of Hematology and Oncology, Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China; (2) Department of Medicine, VA Boston Healthcare System, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussetts, USA; (3) Heilongjiang Institute of Hematology and Oncology, Department of Hematology, Harbin, China

(1) Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Ontario, Canada; (2) Department of Chemistry Biochemistry, University of Windsor, Windsor, Ontario, Canada

(1) Department of Pharmacotherapy and Translational Research, Center for Pharmacogenomics, College of Pharmacy, University of Florida, Gainesville, Florida, USA; (2) Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA; (3) Department of Medicine, University of Chicago, Chicago, Illinois, USA; (4) Pharmaceutical Sciences Section, College of Pharmacy, Qatar University, Doha, Qatar; (5) Univeristy of North Carolina Institute for Pharmacogenomics and Individualized Therapy, Chapel Hill, North Carolina, USA

(1) Department of Clinical and Experimental Medicine, Federico II University, Naples; (2) Istituto Nazionale di Statistica, Palermo; (3) Medical School, University of Ferrara, Ferrara, Italy

(1) High Technology Research Center, Showa Pharmaceutical University, Higashi Tamagawa Gakuen, Machida, Tokyo Japan; (2) Department of Molecular and Cellular Pathophysiology, Showa Pharmaceutical University, Higashi Tamagawa Gakuen, Machida, Tokyo Japan; (3) Department of Biochemistry, School of Pharmacy, Tokyo University of Pharmaceutical and Life Science, Horinouchi, Hachioji, Tokyo, Japan

(1) Neuroprotection Research Laboratory, Departments of Neurology and Radiology,Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Charlestown, Massachussetts, USA; (2) The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; (3) Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, New York, USA

(1) Heilongjiang Institute of Hematology and Oncology, Department of Hematology, Harbin, China; (2) Department of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin, China; (3) Department of Medicine, VA Boston Healthcare System, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussetts, USA

(1) Center for Molecular and Vascular Biology, University of Leuven, Belgium; (2) Department of Vascular Medicine and Haemostasis, University Hospitals Leuven, Belgium; (3) Clinical Department, ThromboGenics, Belgium; (4) Clinical Development, BioInvent International, Sweden; (5) Department of Clinical Medicine, University of Insubria, Italy; (6) Department of Epidemiology, University of Maastricht, The Netherlands; (7) Department of Vascular Medicine, Academic Medical Center Amsterdam, The Netherlands; (8) Department of Vascular Surgery, University Medical Center Utrecht, The Netherlands

(1) Department of Cardiovascular Sciences, University of Leicester, Leicester, UK

(1) Department of Pharmacy and Pharmacology, University of Bath, Bath, UK; (2) Department of Veterinary Basic Sciences, Royal Veterinary College, University of London, London, UK; (3) Consortium for Mitochondrial Research (CfMR), University College London, London, UK; (4) Department of Biology and Biotechnology, University of Pavia, Pavia, Italy; (5) Institute of Human Development, The University of Manchester, Manchester, UK; (6) Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, Manchester, UK; (7) Department of Drug Discovery, Nevada Cancer Institute, Las Vegas, Nevada, USA; (8) Department of Neurology, Columbia University Medical Center, New York, New York, USA

(1) Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan

(1) Department of Physiology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; (2) Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania, USA; (3) Department of Pharmacology, Temple University School of Medicine, Philadelphia, Pennsylvania, USA

(1) Department of Haematology-Haemostasis, University Hospital of Tours, Tours Cedex, France; (2) UMR CNRS 7292 and François Rabelais University, Tours, France; (3) Hyphen Biomed, Neuville sur Oise, France; (4) Department of Cardiac Surgery, University Hospital of Tours, Tours Cedex, France

(1) Thrombosis Research Institute, London, UK; (2) University College London, London, UK